COMMUNIQUÉS West-GlobeNewswire

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth
03/06/2026
Announcement Follows the Recent Appointment of Denham Capital Founder Stuart D. Porter — a Three-Decade Energy and Infrastructure Investor — to the Company’s Board of Directors BOCA RATON, FLA, June 03, 2026 (GLOBE [...]
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
03/06/2026
- Registrational expansion cohort enrolled 71 participants; topline data planned for Q1 2027 - WALTHAM, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on [...]
Sparrow Pharmaceuticals Announces Acceptance of Late-Breaking Presentation of Interim Part 1 Results from CAPTAIN-T2D at the Endocrine Society (ENDO) 2026 Annual Meeting
03/06/2026
Sparrow will also present Phase 2 data on cardiometabolic improvements in patients with type 2 diabetes BOSTON, June 03, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals , a targeted cardiometabolic therapeutics company [...]
Xcube.bio Strengthens Board with Appointment of Three Distinguished Non-Executive Directors
03/06/2026
ZUG, Switzerland, June 03, 2026 (GLOBE NEWSWIRE) -- Xcubebio AG, a market entry acceleration engine for innovative biopharma and transformative therapeutics, today announced the appointments of Carinne Brouillon, Pascal [...]
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
03/06/2026
Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups THE WOODLANDS, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Lexicon [...]
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
03/06/2026
First-in-human study of SOT106 to be initiated in second half of 2026, advancing a differentiated LRRC15 ADC toward early clinical signal PRAGUE, Czech Republic, BASEL, Switzerland and BOSTON, June 03, 2026 (GLOBE [...]
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
03/06/2026
WILMINGTON, Del., June 03, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company, today announced the pricing of an [...]
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
03/06/2026
SAN DIEGO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Sapu Nano and Oncotelic Therapeutics (OTCQB:OTLC) today announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) [...]
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
03/06/2026
NAARDEN, The Netherlands and MIAMI, June 03, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
03/06/2026
Collaboration will Assess the Potential Impact of the Combination of Icovamenib and Semaglutide on Physical Function, Body Weight, Body Composition, Muscle Health and Metabolic Outcomes Late-Breaking Preclinical [...]
Earth Science Tech, Inc. (ETST) to Present at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub
03/06/2026
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified portfolio, today announced that Giorgio R. Saumat, CEO and [...]
Mammogen Secures Up to $30 Million Series A Financing Backed by Leading U.S. Public Retirement System to Advance Blood-Based RNA Breast Cancer Detection Platform
03/06/2026
Institutional financing supports pivotal prospective clinical advancement and commercialization of Mammogen’s RNA-powered molecular diagnostics platform NEWPORT BEACH, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Mammogen [...]
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
03/06/2026
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line Phase 3 data expected year-end 2026 or early 2027 Novel [...]
Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
03/06/2026
- Joint partnership leverages Alpha Tau’s highly potent, localized alpha-radiation technology and Tolmar’s commercial leadership to transform the U.S. uro-oncology landscape - Collaboration elevates prostate cancer as a [...]
ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
03/06/2026
Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging Validates Value of Integrating ENvue [...]
It's Not a Prenatal Class, It's a Social Club With a Curriculum for Parenthood — Launching in Miami This August
03/06/2026
Expecting Together is bringing clinician-led education, meaningful connection, and real community to expecting families across Miami MIAMI, June 03, 2026 (GLOBE NEWSWIRE) -- Miami has attracted transplants, globally [...]
Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
03/06/2026
Palvella remains on track to submit an NDA in the second half of 2026 Microcystic lymphatic malformations are serious, chronic, lifelong vascular malformations that can cause persistent leaking, bleeding, infection, [...]
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
03/06/2026
AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, biotechnology companies are [...]
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
03/06/2026
RENO, Nev., June 03, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, will ring the Nasdaq Closing Bell on Wednesday, [...]

Pages